HC Wainwright Reiterates $34 Price Target on Lantern Pharma

Nov. 12, 2021

Lantern Pharma (NASDAQ: LTRN) is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies. By leveraging RADR®, Lantern's proprietary big data engine, more effective cancer treatments can be developed and delivered to the right group of patients at a faster rate and for a fraction of the cost. RADR® identifies genetic signature patterns that underpin the identification of patients for whom Lantern's portfolio of oncology drug candidates is likely to have the greatest therapeutic effect. This is the future of precision medicine, and Lantern is at the forefront of AI driven transformation…Read More

Killi Sales Momentum Growing

Aug. 12, 2021

Replace ‘Woke’ Teachers With A.I. Mentors?

Apr. 28, 2021

Bring on the A.I. Mentors, Millions of Students Need Them

Apr. 7, 2021

John Dewey’s Legacy Runs Deep in Roblox, the Highest Valued Edtech Company in the Industry

Mar. 4, 2021

Small Stocks Buy Book

Small-Cap Lesson of the Week

Learn from our 20+ years of experience in small-cap stocks with lessons on key investment issues.

Mitigate Risk by Buying Small-Caps in Bunches

Nov. 22, 2021

Constant Dollar Plan

Nov. 15, 2021

Map Your Course

Nov. 8, 2021

MidSouth Week in Review

Weekly update from Buzz Heidtke, a leading small-cap fund manager.

MidSouth Week in Review November 19, 2021

Nov. 22, 2021

MidSouth Week in Review November 12, 2021

Nov. 15, 2021

MidSouth Week in Review November 05, 2021

Nov. 8, 2021

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

Bob McCooey, Senior Vice President, NASDAQ Stock Market

1-800-REDCHIP (733-2447) | 431 E Horatio Ave, Suite #100, Maitland, FL 32751

"Discovering Tomorrow's Blue Chips Today." ® | Home | Contact | Privacy Policy | Disclosures

© 2021 RedChip Companies, Inc.